R1	AND Arg1:T8 Arg2:T9	
*	OR T3 T6 T5 T4 T8 T7
R2	Has_qualifier Arg1:T1 Arg2:T2	
R3	Subsumes Arg1:T1 Arg2:T3	
R4	Subsumes Arg1:T13 Arg2:T14	
R5	Has_qualifier Arg1:T12 Arg2:T13	
R6	Has_qualifier Arg1:T15 Arg2:T16	
R7	Has_value Arg1:T19 Arg2:T18	
R8	AND Arg1:T17 Arg2:T19	
R9	AND Arg1:T21 Arg2:T20	
*	OR T20 T22
R10	Has_mood Arg1:T28 Arg2:T29	
*	OR T26 T27 T28
*	OR T24 T25
R11	Has_qualifier Arg1:T31 Arg2:T23	
R12	Has_context Arg1:T24 Arg2:T31	
R13	Subsumes Arg1:T24 Arg2:T26	
R14	AND Arg1:T37 Arg2:T35	
*	OR T35 T38
R15	AND Arg1:T34 Arg2:T39	
T1	Condition 23 39	systemic disease
T2	Qualifier 0 22	Clinically significant
T3	Condition 49 57	diabetes
T4	Condition 59 77	metabolic syndrome
T5	Condition 79 101	immunological diseases
T6	Condition 103 126	diagnosed thrombophilia
T7	Condition 128 137	porphyria
T8	Condition 152 169	medical condition
T9	Drug 191 219	low-molecular weight heparin
T12	Condition 230 262	Polycystic ovary syndrome (PCOS)
T13	Qualifier 276 304	Rotterdam Consensus Criteria
T14	Qualifier 306 423	European Society of Human Reproduction and Embryology [ESHRE]/American Society for Reproductive Medicine [ASRM], 2003
T15	Condition 426 453	Poor ovarian response (POR)
T16	Qualifier 471 541	European Society of Human Reproduction and Embryology (ESHRE) Criteria
T17	Condition 543 578	RIF (repeated implantation failure)
T18	Value 591 623	greater than or equals to (>=) 2
T19	Measurement 624 656	previous failed embryo transfers
T20	Condition 658 671	Endometriosis
T21	Qualifier 672 684	III-IV stage
T22	Condition 688 699	adenomyosis
T23	Qualifier 701 723	Clinically significant
T24	Procedure 736 740	exam
T25	Procedure 744 754	ultrasound
T26	Condition 764 775	salpingitis
T27	Condition 777 789	hydrosalpynx
T28	Condition 805 818	ovarian cysts
T29	Mood 793 801	evidence
T31	Observation 724 732	findings
T34	Condition 826 842	hypersensitivity
T36	Non-representable 820 884	Known hypersensitivity to any of the components of the solution
T37	Condition 891 907	hypersensitivity
T35	Drug 911 931	vaginal progesterone
T38	Drug 939 949	excipients
T39	Drug 857 883	components of the solution
T40	Non-representable 951 1004	Other protocol defined exclusion criteria could apply
